Search Results

The Glioblastoma Foundation is proud to be a charity partner for the 2024 Los Angeles Marathon for the 5th year.

EDETEK, an innovative leader in clinical technology solutions, is pleased to announce its participation in the upcoming AWS Healthcare and Life Sciences Meetup in Los Angeles, CA on May 16th, 2024.

City of Hope and DELFI Diagnostics, Inc. announced a collaboration to utilize DELFI’s FirstLook Lung, a blood-based lung cancer screening test, in a City of Hope clinical study to help improve screening rates in underserved communities in Los Angeles County.

City of Hope®, one of the largest cancer research and treatment organizations in the United States, announced that effective June 10, Angelique L. Richard, Ph.D., R.N., will be chief operating officer of City of Hope National Medical Center, City of Hope Los Angeles, City of Hope Orange County and City of Hope’s Southern California clinical network.

Biocom California, the association representing the California life science industry, released a new report showing California’s life science industry directly provides more than 465,000 jobs in the state and generates $414.2 billion in total business output.

While many describe California as having a tough life sciences market, there’s some optimism that employment opportunities will improve soon, according to California Life Sciences President and CEO Mike Guerra.

Cannabis Bioscience International Holdings (OTC PINK: CBIH) has been valued at $2 Billion following a rigorous evaluation by StoneBridge Advisory, a leading financial advisory firm based in Los Angeles, California.

EvoEndo®, Inc. is pleased to announce that Children’s Hospital Los Angeles is the first care center in California to use the EvoEndo® Single-Use Endoscopy System to perform a diagnostic unsedated TNE of the Upper Gastrointestinal Tract.

For the first eight months of 2024, California had the most job postings live on BioSpace—37.7% more than Massachusetts. Last year, Massachusetts ranked No.1 for the same time period.

A groundbreaking study conducted by researchers at the University of California Los Angeles and MicroGenDX unveils a potential link between bacterial profiles and male infertility.